Search Orphan Drug Designations and Approvals
-
| Generic Name: | a phosphoramidate oral prodrug of a unique 6-modified purine nucleotide |
|---|---|
| Date Designated: | 12/18/2023 |
| Orphan Designation: | Treatment of disease caused by dengue virus |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Atea Pharmaceuticals Inc. 225 Franklin Street Suite 2100 Boston, Massachusetts 02110 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







